logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Meng Dong

Jiangnan University
H指数:13
被引数:762

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review

吉非替尼联合贝伐珠单抗在一名接受奥希替尼治疗后出现获得性C797S突变非小细胞肺癌患者中产生持久的临床获益：病例报告与文献综述

Frontiers in Oncology
IF3.3
2025-10-130
OAAI
Yuping Tan†; Meng Dong†; Xi Li; Wenbo Li; Fei Xiong; Weidong Bao; Yongzhou Dai; Linjun Yue; Yuan Liu
Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

与含高剂量甲氨蝶呤方案相比，足叶乙苷基化疗药物表现出显著降低的毒性，且疗效相当。

BLOOD
IF23.1
2024-11-050
PRE
Zhang, Xudong; Fan, Mengke; Wang, Wenhua; Wu, Jingjing; Ma, Shanshan; Dong, Meng; Zhu, Linan; Wu, Xiaolong; Feng, Xiaoyan; Li, Xin; Li, Ling; Sun, Zhenchang; Wang, Xinhua; Fu, Xiaorui; Li, Zhaoming; Yan, Jiaqin; Chang, Yu; Yu, Hui; Nan, Feifei; Zhou, Zhiyuan; Ding, Mengjie; Zhang, Jieming; Zhang, Lei; Zhang, Mingzhi
Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer
NATURE COMMUNICATIONS
IF15.7
2023-09-1111
OAAI
Sun, Handong; Zhang, Lishen; Wang, Zhonglin; Gu, Danling; Zhu, Mengyan; Cai, Yun; Li, Lu; Tang, Jiaqi; Huang, Bin; Bosco, Bakwatanisa; Li, Ning; Wu, Lingxiang; Wu, Wei; Li, Liangyu; Liang, Yuan; Luo, Lin; Liu, Quanzhong; Zhu, Yanhui; Sun, Jie; Shi, Liang; Xia, Tiansong; Yang, Chuang; Xu, Qitong; Han, Xue; Zhang, Weiming; Liu, Jianxia; Meng, Dong; Shao, Hua; Zheng, Xiangxin; Li, Shuqin; Pan, Hua; Ke, Jing; Jiang, Wenying; Zhang, Xiaolan; Han, Xuedong; Chu, Jian; An, Hongyin; Ge, Juyan; Pan, Chi; Wang, Xiuxing; Li, Kening; Wang, Qianghu; Ding, Qiang
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study

奥列拉布替尼-布鲁顿酪氨酸激酶抑制剂方案治疗中枢神经系统淋巴瘤的回顾性研究

INVESTIGATIONAL NEW DRUGS
IF2.7
2022-02-0921
PRE
Wu, Jing-Jing; Wang, Wen-Hua; Dong, Meng; Ma, Shan-Shan; Zhang, Xu-Dong; Zhu, Li-Nan; Niu, Song-Tao; Ding, Meng-Jie; Zhang, Jie-Ming; Zhang, Lei; Li, Xin; Li, Ling; Sun, Zhen-Chang; Wang, Xin-Hua; Fu, Xiao-Rui; Li, Zhao-Ming; Chang, Yu; Nan, Fei-Fei; Yan, Jia-Qin; Yu, Hui; Wu, Xiao-Long; Zhou, Zhi-Yuan; Zhang, Ming-Zhi
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

以福莫司汀为基础的治疗与利妥昔单抗联合作为一线诱导化疗，然后进行WBRT治疗新诊断的原发性中枢神经系统淋巴瘤: 一项前瞻性II期试验

CANCER BIOLOGY & MEDICINE
IF8.4
2021-10-121
OAAI
Wu, Jingjing; Gao, Fenghua; Wang, Wenhua; Zhang, Xudong; Dong, Meng; Zhang, Lei; Li, Xin; Li, Ling; Sun, Zhenchang; Wang, Xinhua; Fu, Xiaorui; Zhu, Linan; Ding, Mengjie; Niu, Songtao; Li, Zhaoming; Chang, Yu; Nan, Feifei; Yan, Jiaqian; Yu, Hui; Wu, Xiaolong; Zhou, Zhiyuan; Zhang, Jieming; Zhang, Mingzhi
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure
FRONTIERS IN ONCOLOGY
IF3.3
2021-06-189
OAAI
Hu, Junxia; Wang, Xin; Chen, Fei; Ding, Mengjie; Dong, Meng; Yang, Wanqiu; Yin, Meifeng; Wu, Jingjing; Zhang, Lei; Fu, Xiaorui; Sun, Zhenchang; Li, Ling; Wang, Xinhua; Li, Xin; Guo, Shuangshuang; Zhang, Dianbao; Lu, Xiaohui; Leng, Qing; Zhang, Mingzhi; Zhu, Linan; Zhang, Xudong; Chen, Qingjiang
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
BREAST CANCER RESEARCH AND TREATMENT
IF3
2017-12-1129
PREAI
Xie, Jie; Cao, Jun; Wang, Jing-fen; Zhang, Bai-hong; Zeng, Xiao-hua; Zheng, Hong; Zhang, Yang; Cai, Li; Wu, Yu-dong; Yao, Qiang; Zhao, Xiao-chun; Mao, Wei-dong; Jiang, Ai-Mei; Chen, Shao-shui; Yang, Shun-e; Wang, Shu-sen; Wang, Jian-hong; Pan, Yue-yin; Ren, Bi-yong; Chen, Yan-ju; Ouyang, Li-zhi; Lei, Kai-jian; Gao, Jing-hua; Huang, Wen-he; Huang, Zhan; Shou, Tao; He, Yan-ling; Cheng, Jing; Sun, Yang; Li, Wei-ming; Cui, Shu-de; Wang, Xin; Rao, Zhi-guo; Ma, Hu; Liu, Wei; Wu, Xue-yong; Shen, Wei-xi; Cao, Fei-lin; Xiao, Ze-min; Wu, Biao; Tian, Shu-yan; Meng, Dong; Shen, Peng; Wang, Bi-yun; Wang, Zhonghua; Zhang, Jian; Wang, Leiping; Hu, Xi-chun

研究方向

暂未获取到该数据
X
Xinhua Wang
H 指数:40论文数:370被引数:5,704
X
Xiaorui Fu
H 指数:24论文数:149被引数:2,123
M
Mingzhi Zhang
H 指数:38论文数:359被引数:5,475
L
Linan Zhu
H 指数:9论文数:40被引数:379
M
Mengjie Ding
H 指数:9论文数:37被引数:301
Z
Zhaoming Li
H 指数:34论文数:237被引数:4,145
L
Ling Li
H 指数:31论文数:152被引数:3,139
W
Wu, Jingjing
H 指数:0论文数:3被引数:61
X
Xudong Zhang
H 指数:22论文数:142被引数:1,977
Y
Yu Chang
H 指数:32论文数:148被引数:3,656